The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Crenolanib besylate, a type I pan-FLT3 inhibitor, to demonstrate clinical activity in multiply relapsed FLT3-ITD and D835 AML.
 
Jorge E. Cortes
Consulting or Advisory Role - Ambit BioSciences; Amphivena Therapeutics; ARIAD; Astellas Pharma; BiolineRx; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Teva (Inst)
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Delta-Fly Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Tapan M. Kadia
Consulting or Advisory Role - ARIAD; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Gautam Borthakur
Consulting or Advisory Role - Novartis
Research Funding - GlaxoSmithKline; Lilly
 
Marina Konopleva
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Abbvie; Calithera Biosciences; Genentech
Consulting or Advisory Role - AbbVie
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Stemline Therapeutics (Inst)
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Naval Guastad Daver
No Relationships to Disclose
 
Naveen Pemmaraju
Honoraria - Incyte; LFB Biotechnologies; Novartis
Consulting or Advisory Role - Incyte; LFB Biotechnologies; Novartis
Research Funding - Incyte; Novartis; Stemline Therapeutics
 
Elias Jabbour
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Zeev Estrov
No Relationships to Disclose
 
Abhijit Ramachandran
Employment - Arog
 
Jamil Paradela
No Relationships to Disclose
 
Blake Pond
No Relationships to Disclose
 
Farhad Ravandi
Honoraria - Amgen; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Amgen; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen; Bristol-Myers Squibb; Merck; Seagen; Sunesis Pharmaceuticals
 
Madhuri Vusirikala
Honoraria - Amgen; Seagen
Consulting or Advisory Role - Amgen; Seagen
 
Prapti Arvind Patel
No Relationships to Disclose
 
Mark J. Levis
Consulting or Advisory Role - Amgen; Astex Pharmaceuticals; Daiichi Sankyo
Research Funding - Astellas Pharma (Inst); Novartis (Inst)
 
Alexander E. Perl
Honoraria - Dava Oncology
Consulting or Advisory Role - Actinium Pharmaceuticals; Arog; Asana biosciences; Astellas Pharma; Seagen
 
Michael Andreeff
Leadership - Oncoceutics
Stock and Other Ownership Interests - Aptose Biosciences; Eutropics; Oncoceutics; Reata Pharmaceuticals; Roche
Consulting or Advisory Role - Amgen; Roche
Research Funding - Daiichi Sankyo; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Reata Pharmaceuticals
 
Robert Collins
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer; Raindance Technologies
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Raindance Technologies